A modified transcondylar screw to accommodate anatomical skull base variations.
CONCLUSION: The modified mTCS technique allows for direct visualization and, therefore, helps to avoid damage to the hypoglossal nerve and lateral aspect of brain stem. PMID: 28695045 [PubMed - in process]
CONCLUSION POD is prevalent in patients after elective intracranial surgery. The identified risk factors for and the potential association of POD with adverse outcomes suggest that a comprehensive strategy involving screening for predisposing factors and early prevention of modifiable factors should be established in this population. TRIAL REGISTRATION ClinicalTrials.gov NCT03087838.
ConclusionLON injury during retrosigmoid craniotomy can lead to occipital neuralgia and significant patient distress. Surgeons should be aware of the LON’s course relative to retrosigmoid incisions. Repair of the injured nerve with processed cadaveric nerve allograft deserves continued investigation for treating LON damage.
CONCLUSIONS: There is high-quality evidence that NSAIDs reduce pain up to 24 hours postoperatively. The evidence for reductions in pain with dexmedetomidine, pregabalin or gabapentin, scalp blocks, and scalp infiltration is less certain and of very low to moderate quality. There is low-quality evidence that scalp blocks and dexmedetomidine may reduce additional analgesics requirements. There is low-quality evidence that gabapentin or pregabalin may decrease nausea and vomiting, with the caveat that the total number of events for this comparison was low. PMID: 31747720 [PubMed - in process]
Conditions: Postoperative Pain; Lidocaine Interventions: Drug: Lidocaine 5% patch; Drug: Placebo patch Sponsor: Beijing Tiantan Hospital Not yet recruiting
Conclusion: Scalp block might be useful at <6 h postcraniotomy with very-low quality evidence. Additionally, it had uncertain but moderate effect on reducing total 24 h opioid consumption. Therefore, more studies are needed to reach optimal information size.
Conditions: Pain; Supratentorial Brain Tumor Interventions: Drug: Ketorolac; Drug: Ropivacaine; Drug: Epinephrine Sponsor: Beijing Tiantan Hospital Not yet recruiting